Metasphere Labs Inc.
LABZ
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 672.90K | 1.14M | 1.62M | 1.79M | 1.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 672.90K | 1.14M | 1.62M | 1.79M | 1.30M |
| Cost of Revenue | 132.10K | 188.50K | 259.50K | 282.20K | 208.00K |
| Gross Profit | 540.90K | 950.60K | 1.36M | 1.51M | 1.09M |
| SG&A Expenses | 811.70K | 804.30K | 770.70K | 844.80K | 889.20K |
| Depreciation & Amortization | 62.70K | 67.30K | 82.40K | 86.30K | 118.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.04M | 1.10M | 1.13M | 1.22M | 1.22M |
| Operating Income | -369.00K | 43.50K | 486.30K | 577.40K | 76.80K |
| Income Before Tax | -892.50K | -439.50K | -2.10K | -266.80K | -2.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.89 | -0.44 | 0.00 | -0.27 | -2.49 |
| Earnings from Discontinued Operations | -- | -- | -- | 30.20K | 5.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -892.50K | -439.50K | -2.10K | -236.60K | -2.48M |
| EBIT | -369.00K | 43.50K | 486.30K | 577.40K | 76.80K |
| EBITDA | -350.90K | 61.90K | 515.20K | 643.10K | 139.40K |
| EPS Basic | -0.03 | 0.00 | 0.11 | -0.33 | -1.49 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.07 | 0.02 | -0.13 |
| EPS Diluted | -0.03 | -0.01 | 0.10 | -0.33 | -1.50 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.07 | 0.01 | -0.13 |
| Average Basic Shares Outstanding | 149.80M | 125.00M | 89.91M | 61.30M | 22.90M |
| Average Diluted Shares Outstanding | 166.09M | 154.17M | 119.08M | 90.47M | 35.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
